206 related articles for article (PubMed ID: 23578364)
1. Dietary flavonol epicatechin prevents the onset of type 1 diabetes in nonobese diabetic mice.
Fu Z; Yuskavage J; Liu D
J Agric Food Chem; 2013 May; 61(18):4303-9. PubMed ID: 23578364
[TBL] [Abstract][Full Text] [Related]
2. Epigallocatechin gallate delays the onset of type 1 diabetes in spontaneous non-obese diabetic mice.
Fu Z; Zhen W; Yuskavage J; Liu D
Br J Nutr; 2011 Apr; 105(8):1218-25. PubMed ID: 21144096
[TBL] [Abstract][Full Text] [Related]
3. 2α-Methyl-19-nor-(20S)-1,25-dihydroxyvitamin D(3) protects the insulin 2 knockout non-obese diabetic mouse from developing type 1 diabetes without hypercalcaemia.
Kiekhaefer CM; Weber B; Huggins M; Gorichanaz C; Nehring JA; DeLuca HF
Clin Exp Immunol; 2011 Dec; 166(3):325-32. PubMed ID: 22059989
[TBL] [Abstract][Full Text] [Related]
4. The novel anti-inflammatory agent lisofylline prevents autoimmune diabetic recurrence after islet transplantation.
Yang Z; Chen M; Ellett JD; Fialkow LB; Carter JD; Nadler JL
Transplantation; 2004 Jan; 77(1):55-60. PubMed ID: 14724435
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D supplementation induces CatG-mediated CD4
Lai X; Liu X; Cai X; Zou F
Am J Physiol Endocrinol Metab; 2022 Jan; 322(1):E74-E84. PubMed ID: 34779254
[TBL] [Abstract][Full Text] [Related]
6. A Novel Liposome Formulation Carrying Both an Insulin Peptide and a Ligand for Invariant Natural Killer T Cells Induces Accumulation of Regulatory T Cells to Islets in Nonobese Diabetic Mice.
Akimoto H; Fukuda-Kawaguchi E; Duramad O; Ishii Y; Tanabe K
J Diabetes Res; 2019; 2019():9430473. PubMed ID: 31781669
[TBL] [Abstract][Full Text] [Related]
7. IFN-γ induced by IL-12 administration prevents diabetes by inhibiting pathogenic IL-17 production in NOD mice.
Zhang J; Huang Z; Sun R; Tian Z; Wei H
J Autoimmun; 2012 Feb; 38(1):20-8. PubMed ID: 22186068
[TBL] [Abstract][Full Text] [Related]
8. Abnormal cannabidiol ameliorates inflammation preserving pancreatic beta cells in mouse models of experimental type 1 diabetes and beta cell damage.
González-Mariscal I; Pozo-Morales M; Romero-Zerbo SY; Espinosa-Jimenez V; Escamilla-Sánchez A; Sánchez-Salido L; Cobo-Vuilleumier N; Gauthier BR; Bermúdez-Silva FJ
Biomed Pharmacother; 2022 Jan; 145():112361. PubMed ID: 34872800
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic Alpha-Cells Contribute Together With Beta-Cells to CXCL10 Expression in Type 1 Diabetes.
Nigi L; Brusco N; Grieco GE; Licata G; Krogvold L; Marselli L; Gysemans C; Overbergh L; Marchetti P; Mathieu C; Dahl Jørgensen K; Sebastiani G; Dotta F
Front Endocrinol (Lausanne); 2020; 11():630. PubMed ID: 33042009
[TBL] [Abstract][Full Text] [Related]
10. Proposed mechanisms for oligonucleotide IMT504 induced diabetes reversion in a mouse model of immunodependent diabetes.
Bianchi MS; Bianchi S; Hernado-Insúa A; Martinez LM; Lago N; Libertun C; Chasseing NA; Montaner AD; Lux-Lantos VA
Am J Physiol Endocrinol Metab; 2016 Aug; 311(2):E380-95. PubMed ID: 27329801
[TBL] [Abstract][Full Text] [Related]
11. The anti-inflammatory compound lisofylline prevents Type I diabetes in non-obese diabetic mice.
Yang ZD; Chen M; Wu R; McDuffie M; Nadler JL
Diabetologia; 2002 Sep; 45(9):1307-14. PubMed ID: 12242464
[TBL] [Abstract][Full Text] [Related]
12. Tolerogenic Immune-Modifying Nanoparticles Encapsulating Multiple Recombinant Pancreatic β Cell Proteins Prevent Onset and Progression of Type 1 Diabetes in Nonobese Diabetic Mice.
Podojil JR; Genardi S; Chiang MY; Kakade S; Neef T; Murthy T; Boyne MT; Elhofy A; Miller SD
J Immunol; 2022 Aug; 209(3):465-475. PubMed ID: 35725270
[TBL] [Abstract][Full Text] [Related]
13. Lazaroid antioxidant reduces incidence of diabetes and insulitis in nonobese diabetic mice.
Rabinovitch A; Suarez WL; Power RF
J Lab Clin Med; 1993 Apr; 121(4):603-7. PubMed ID: 8454942
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-4 or interleukin-10 expressed from adenovirus-transduced syngeneic islet grafts fails to prevent beta cell destruction in diabetic NOD mice.
Smith DK; Korbutt GS; Suarez-Pinzon WL; Kao D; Rajotte RV; Elliott JF
Transplantation; 1997 Oct; 64(7):1040-9. PubMed ID: 9381527
[TBL] [Abstract][Full Text] [Related]
15. Insulin sensitizer prevents and ameliorates experimental type 1 diabetes.
Valitsky M; Hoffman A; Unterman T; Bar-Tana J
Am J Physiol Endocrinol Metab; 2017 Dec; 313(6):E672-E680. PubMed ID: 28270441
[TBL] [Abstract][Full Text] [Related]
16. 1,25-Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in nonobese diabetic mice.
Gysemans CA; Cardozo AK; Callewaert H; Giulietti A; Hulshagen L; Bouillon R; Eizirik DL; Mathieu C
Endocrinology; 2005 Apr; 146(4):1956-64. PubMed ID: 15637289
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of combined intervention with adenovirus vector mediated IL-10 and IGF-1 genes on endogenous islet β cells in nonobese diabetes mice with onset of type 1 diabetes mellitus.
Zhang L; Chen Y; Li C; Lin X; Cheng X; Li T
PLoS One; 2014; 9(3):e92616. PubMed ID: 24663217
[TBL] [Abstract][Full Text] [Related]
18. Boswellic extracts and 11-keto-ß-boswellic acids prevent type 1 and type 2 diabetes mellitus by suppressing the expression of proinflammatory cytokines.
Ammon HPT
Phytomedicine; 2019 Oct; 63():153002. PubMed ID: 31301539
[TBL] [Abstract][Full Text] [Related]
19. PAHSAs attenuate immune responses and promote β cell survival in autoimmune diabetic mice.
Syed I; Rubin de Celis MF; Mohan JF; Moraes-Vieira PM; Vijayakumar A; Nelson AT; Siegel D; Saghatelian A; Mathis D; Kahn BB
J Clin Invest; 2019 Aug; 129(9):3717-3731. PubMed ID: 31380811
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice.
Shapiro AM; Suarez-Pinzon WL; Power R; Rabinovitch A
Diabetologia; 2002 Feb; 45(2):224-30. PubMed ID: 11935154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
